LRRK2 mutations are associated with a variable degree of Lewy body burden35, and individuals with LRRK2 G2019S may have non-Lewy body pathology, such as progressive supranuclear palsy, corticobasal degeneration, or amyotrophic lateral sclerosis36,37. Here, LRRK2 is linked to Classical progressive supranuclear palsy.